These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Moran MJ, Fontanellas A, Brudieux E, Hombrados I, de Ledinghen V, Couzigou P, de Verneuil H, De Salamanca RE. Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661 [Abstract] [Full Text] [Related]
8. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake. Mukerji SK. Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304 [Abstract] [Full Text] [Related]
9. [Hepatitis C, hemochromatosis and porphyria cutanea tarda]. Teubner A, Richter M, Schuppan D, Köstler E, Stölzel U. Dtsch Med Wochenschr; 2006 Mar 31; 131(13):691-5. PubMed ID: 16555178 [Abstract] [Full Text] [Related]
11. [The frequency of viral hepatitis C in patients with porphyria cutanea tarda]. Malina L, Arenberger P, Kracíková J. Cas Lek Cesk; 1994 Oct 10; 133(19):599-601. PubMed ID: 7525065 [Abstract] [Full Text] [Related]
16. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients. Dabrowska E, Jabłońska-Kaszewska I, Bielawski KP, Falkiewicz B. Med Sci Monit; 2001 May 10; 7 Suppl 1():190-6. PubMed ID: 12211718 [Abstract] [Full Text] [Related]